[1] If you notice any new or worsening visual symptoms, arrange an urgent ophthalmic review
PIONEER 4 PIONEER 4 was an important trial comparing the addition of oral semaglutide or liraglutide to background metformin with or without an SGLT-2 inhibitor in patients with T2DM
tryptophan cannot be transferred into the brain
Findings: Weight Loss and Hormonal Restoration Over the course of treatment, participants achieved an average weight reduction of 10%
however, theoretical risks include off-target activation of the HGF/c-Met pathway, which is implicated in oncogenesis, warranting caution regarding long-term use
You should work with your FP counsel when making these decisions, as this is a developing area that can potentially trigger various compliance issues, including issues beyond the scope of these FAQs